CS logo
small CS logo
University of Kansas Cancer Center-Overland Park

Overland Park, Kansas, United States
Cancer treatment center in Overland Park, Kansas
12200 W 110th St, Overland Park, KS 66210

About University of Kansas Cancer Center-Overland Park


"The University of Kansas Cancer Center offers cancer treatment in Overland Park, Kansas. Patients have even greater access to treatment options and clinical trials available only at a National Cancer Institute-designated cancer center."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
83
SWOG Cancer Research Network
30
NRG Oncology
21
Alliance for Clinical Trials in Oncology
13
University of Kansas Medical Center
9
ECOG-ACRIN Cancer Research Group
6
Priyanka Sharma
3
Qamar Khan
3
Pfizer
2
Radiation Therapy Oncology Group
2
SCRI Development Innovations, LLC
2
Total Rows: 33

Clinical Trials at University of Kansas Cancer Center-Overland Park


During the past decade, University of Kansas Cancer Center-Overland Park conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 55 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 39 clinical trials were completed. i.e. 125.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years141412122323171735351717886611335544339915151010Started TrialsCompleted Trails2015201620172018201920202021202202040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel
2005-12-01
Completed
40
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
2004-08-01
2009-05-01
Completed
100
Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer
2005-05-31
2009-03-31
Completed
150
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
2005-12-01
2014-09-01
Completed
4,172
Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
2006-02-01
Terminated
400
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
2007-12-01
Active, not recruiting
427

Rows per page:

1–100 of 197

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "University of Kansas Cancer Center-Overland Park" #1 sponsor was "National Cancer Institute (NCI)" with 83 trials, followed by "SWOG Cancer Research Network" with 30 trials sponsored, "NRG Oncology" with 21 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored and "University of Kansas Medical Center" with 13 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 33 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Cancer Center-Overland Park" #1 collaborator was "National Cancer Institute (NCI)" with 73 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Radiation Therapy Oncology Group" with 4 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 35 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 83National CancerInstitute (NCI): 83SWOG Cancer ResearchNetwork: 30SWOG Cancer ResearchNetwork: 30NRG Oncology: 21NRG Oncology: 21Alliance for ClinicalTrials in Oncology: 13Alliance for ClinicalTrials in Oncology: 13University of KansasMedical Center: 9University of KansasMedical Center: 9ECOG-ACRIN CancerResearch Group: 6ECOG-ACRIN CancerResearch Group: 6Priyanka Sharma: 3Priyanka Sharma: 3Qamar Khan: 3Qamar Khan: 3Pfizer: 2Pfizer: 2Radiation TherapyOncology Group: 2Radiation TherapyOncology Group: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 73National CancerInstitute (NCI): 73NRG Oncology: 17NRG Oncology: 17Canadian Cancer Trials Group: 8Canadian Cancer Trials Group: 8Radiation TherapyOncology Group: 4Radiation TherapyOncology Group: 4Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3Novartis Pharmaceuticals: 3Novartis Pharmaceuticals: 3Bayer: 2Bayer: 2Gilead Sciences: 2Gilead Sciences: 2Medivation, Inc.: 2Medivation, Inc.: 2Pfizer: 2Pfizer: 2

Clinical Trials Conditions at University of Kansas Cancer Center-Overland Park


According to Clinical.Site data, the most researched conditions in "University of Kansas Cancer Center-Overland Park" are "Breast Cancer" (12 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials) and "Invasive Breast Carcinoma" (6 trials). Many other conditions were trialed in "University of Kansas Cancer Center-Overland Park" in a lesser frequency.

Clinical Trials Intervention Types at University of Kansas Cancer Center-Overland Park


Most popular intervention types in "University of Kansas Cancer Center-Overland Park" are "Drug" (155 trials), "Other" (91 trials), "Biological" (66 trials), "Radiation" (58 trials) and "Procedure" (52 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Quality-of-Life Assessment" (41 trials), "Biospecimen Collection" (31 trials), "Computed Tomography" (29 trials) and "Questionnaire Administration" (25 trials). Other intervention names were less common.

Clinical Trials Genders at University of Kansas Cancer Center-Overland Park


The vast majority of trials in "University of Kansas Cancer Center-Overland Park" are 158 trials for "All" genders, 22 trials for "Female" genders and 17 trials for "Male" genders.

Clinical Trials Status at University of Kansas Cancer Center-Overland Park


Currently, there are NaN active trials in "University of Kansas Cancer Center-Overland Park". undefined are not yet recruiting, 60 are recruiting, 89 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in University of Kansas Cancer Center-Overland Park, 7 suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in University of Kansas Cancer Center-Overland Park, 26 "Phase 1" clinical trials were conducted, 111 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 111Phase 2: 111Phase 3: 90Phase 3: 90Phase 1: 26Phase 1: 26Not Applicable: 5Not Applicable: 5

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 89Active, not recruiting: 89Recruiting: 60Recruiting: 60Completed: 36Completed: 36Suspended: 7Suspended: 7Terminated: 4Terminated: 4Withdrawn: 1Withdrawn: 1